PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | C0007222|cardiovascular diseases |
| Sentences | 26 |
| PubMedID- 25294497 | cardiovascular diseases arising from atherosclerosis are currently the leading cause of mortality worldwide. |
| PubMedID- 24890098 | The pathogenesis of atherosclerosis, the major cause of cardiovascular diseases (cvd), is multifactorial and therefore its treatment approaches and the ability to regress the plaque are complicated. |
| PubMedID- 24688491 | atherosclerosis, the major cause of many cardiovascular diseases, is a chronic inflammatory condition. |
| PubMedID- 23320039 | The usage of repeated heated oil is the predisposing factor of atherosclerosis leading to cardiovascular diseases. |
| PubMedID- 21111933 | On the basis of this mechanism, chronic periodontitis has been suggested as a risk factor for cardiovascular diseases associated with atherosclerosis, bacterial endocarditis, diabetes mellitus, respiratory disease, preterm delivery, rheumatoid arthritis, and, recently, osteoporosis, pancreatic cancer, metabolic syndrome, renal diseases and neurodegenerative diseases such as alzheimer's disease. |
| PubMedID- 23934728 | The most common are cardiovascular diseases (associated with atherosclerosis, hypertension and cardiac hypertrophy), cancer, diabetes (and other complications of metabolic syndrome), alzheimer and parkinson diseases, macular degeneration and so on. |
| PubMedID- 24520379 | Although hypertension is a driver of the development of atherosclerosis underlying cardiovascular diseases, the benefits of calcium channel blockers, and in particular 1,4-dihydropyridines, for the progression of atherosclerosis have been indicated beyond their blood pressure-lowering effects. |
| PubMedID- 20978850 | Both central obesity and increased carotid intima-media thickness (imt) are markers of atherosclerosis and associated with cardiovascular diseases (cvd). |
| PubMedID- 23269933 | cardiovascular diseases due to atherosclerosis pose some of the most important problems of contemporary medicine [1–3]. |
| PubMedID- 23438952 | cardiovascular diseases (cvds), largely due to atherosclerosis, are the major causes of death in today's world. |
| PubMedID- 22719926 | Metabolic syndrome, a consequence of complex interactions between liver and adipose tissue, is well established as a risk factor for atherosclerosis leading to cardiovascular diseases. |
| PubMedID- 26060376 | atherosclerosis leads to the cardiovascular diseases. |
| PubMedID- 24924233 | Background: depression and cardiovascular diseases due to arteriosclerosis are both frequent and impairing conditions. |
| PubMedID- 23843804 | Dyslipidemia is an established risk factor for atherosclerosis, which leads to cardiovascular diseases. |
| PubMedID- 22329947 | Over the decades it has been well approved that in addition to lipid dysfunction and arterial lipid accumulation, inflammation and autoimmune responses are major factors in directing the initiation and progression of atherosclerosis, the underlying cause of cardiovascular diseases. |
| PubMedID- 22500143 | Adipogenic differentiation is another interesting lineage, because fat tissue is considered to be a major factor triggering atherosclerosis that ultimately leads to cardiovascular diseases, the main cause of death in industrialized countries. |
| PubMedID- 23843862 | In addition, a study on the use of repeatedly heated oil (a common practice in asian countries) concluded that it has the predisposing factor of atherosclerosis leading to cardiovascular diseases. |
| PubMedID- 25374046 | Background: hypertension, homocysteine and renal resistive index are associated with atherosclerosis and lead to cardiovascular diseases. |
| PubMedID- 21716746 | atherosclerosis, the primary cause of cardiovascular diseases, affects the medium and large arteries due to the build-up of fat, cholesterol, and other substances on the inner walls of arteries. |
| PubMedID- 23593564 | Homocysteine (hcy) is an intermediate in methionine metabolism.1 a large amount of epidemiological studies2 have confirmed that an increased plasma hcy concentration is an independent risk factor for atherosclerosis leading to cardiovascular diseases. |
| PubMedID- 21223581 | The paraoxonase (pon) genes have received major attention as antioxidants that attenuate oxidation of low density lipoprotein (ldl), a key regulator in the pathogenesis of atherosclerosis leading to several cardiovascular diseases [4]. |
| PubMedID- 24971331 | atherosclerosis is generally associated with cardiovascular diseases such as strokes, heart attacks, and peripheral vascular diseases. |
| PubMedID- 23843828 | Dyslipidemia is one of the most prominent risk factors of atherosclerosis leading to cardiovascular diseases. |
| PubMedID- 21470163 | cardiovascular diseases, including atherosclerosis and the dreaded complication myocardial infarction, represent the major cause of death in western countries. |
| PubMedID- 24103860 | These antioxidants have been shown to inhibit lipid peroxidation in vitro, particularly that of low-density lipoproteins (ldl)32 responsible for the development of atherosclerosis,33 the primary cause of cardiovascular diseases, which have been shown to be related to frailty in several cross-sectional studies.34 although several prospective studies demonstrated that fruit and vegetable consumption is protective against noncommunicable diseases, particularly cardiovascular diseases,35 the beneficial effect may not be due to isolated individual antioxidant compounds included in fruits and vegetables, as important meta-analyses of randomized controlled trials failed to show a beneficial effect of vitamins e, c, or β-carotene,36 rather joint effects of known or unknown antioxidants. |
| PubMedID- 25911913 | cardiovascular diseases caused death of patients with atherosclerosis of coronary arteries and fatty regeneration of a liver, than in group of patients without a fatty degeneration of a liver (91.7 +/- 4.8% of cases and 73.8 +/- 4.9% of cases respectively) more often. |
Page: 1